Kintara Therapeutics Analysis

Kintara Therapeutics is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Kintara Therapeutics delisted stock analysis is to determine its intrinsic value, which is an estimate of what Kintara Therapeutics is worth, separate from its market price. There are two main types of Kintara Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Kintara Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Kintara Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Kintara Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Kintara Therapeutics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Kintara Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Kintara Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

Kintara Stock Analysis Notes

The company recorded a loss per share of 0.95. Kintara Therapeutics had not issued any dividends in recent years. The entity had 3:1 split on the 8th of May 2019. DelMar Pharmaceuticals, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. DelMar Pharmaceuticals, Inc. was founded in 2009 and is headquartered in San Diego, California. DelMar Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2 people. To learn more about Kintara Therapeutics call Jeffrey Bacha at 858-350-4364 or check out http://www.delmarpharma.com.

Kintara Therapeutics Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Kintara Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Kintara Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Kintara Therapeutics is not yet fully synchronised with the market data
Kintara Therapeutics has some characteristics of a very speculative penny stock
Kintara Therapeutics has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (7.9 M).
Kintara Therapeutics currently holds about 4.97 M in cash with (7.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44.

Kintara Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 15.35 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kintara Therapeutics's market, we take the total number of its shares issued and multiply it by Kintara Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Kintara Therapeutics to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Correlation Analysis Now

   

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
All  Next Launch Module
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Consideration for investing in Kintara Stock

If you are still planning to invest in Kintara Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kintara Therapeutics' history and understand the potential risks before investing.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
CEOs Directory
Screen CEOs from public companies around the world